Blockade of renin angiotensin system increased resistance to STZ-induced diabetes in rats with long-term high-fat diet

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Li, Xin ^a   Yuan, Li ^a   Li, Jin ^a   Li, Hailing ^a   Cheng, Suosuo ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1BETA; TELMISARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AUTACOID; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; CASP3 PROTEIN, RAT; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; ENDOCRINE FUNCTION TEST; GENE EXPRESSION; GLUCOSE CLAMP TECHNIQUE; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; INTRAVENOUS INSULIN RELEASING TEST; LIPID DIET; MALE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; IMPAIRED GLUCOSE TOLERANCE; METABOLISM; PANCREAS ISLET BETA CELL; PATHOLOGY; TIME; WISTAR RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; APOPTOSIS; BENZIMIDAZOLES; BENZOATES; BLOOD GLUCOSE; CASPASE 3; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; GLUCOSE CLAMP TECHNIQUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; INTERLEUKIN-1BETA; MALE; NF-KAPPA B; PREDIABETIC STATE; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOZOCIN; TIME FACTORS;

EID: 84871439658     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/618923     Document Type: Article

References (16)

1. Stumvoll M., Goldstein B. J., Van Haeften T. W., Pathogenesis of type 2 diabetes. Endocrine Research 2006 32 1-2 19 37 2-s2.0-40449118639 10.1080/07435800701743810 (Pubitemid 351411681)
2. Leung P. S., Pancreatic renin-angiotensin system: a novel target for the potential treatment of pancreatic diseases? Journal of the Pancreas 2003 4 2 89 91 2-s2.0-0037365975 (Pubitemid 38963791)
3. Carlsson P. O., The renin-angiotensin system in the endocrine pancreas. Journal of the Pancreas 2001 2 1 26 32 2-s2.0-0035239910
4. Gillespie E. L., White C. M., Kardas M., Lindberg M., Coleman C. I., The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care 2005 28 9 2261 2266 2-s2.0-24144490705 10.2337/diacare.28.9.2261 (Pubitemid 41242483)
5. NAVIGATOR Study Group, McMurray J. J., Holman R. R., Effect of valsartan on the incidence of diabetes and cardiovascular events. The New England Journal of Medicine 2010 362 16 1477 1490
6. Després J. P., Lemieux I., Abdominal obesity and metabolic syndrome. Nature 2006 444 7121 881 887 2-s2.0-33845886915 10.1038/nature05488 (Pubitemid 46024995)
7. Ferrario C. M., Strawn W. B., Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. American Journal of Cardiology 2006 98 1 121 128 2-s2.0-33745162185 10.1016/j.amjcard.2006.01. 059 (Pubitemid 43902687)
8. Schäfer A., Flierl U., Vogt C., Menninger S., Tas P., Ertl G., Bauersachs J., Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus. Pharmacological Research 2007 56 3 217 223 2-s2.0-34548293808 10.1016/j.phrs.2007.05.009 (Pubitemid 47321205)
9. Kraegen E. W., James D. E., Bennett S. P., Chisholm D. J., In vivo insulin sensitivity in the rat determined by euglycemic clamp. The American Journal of Physiology 1983 245 1 E1 E7 2-s2.0-0020791161 (Pubitemid 14230298)
10. Henriksen E. J., Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. American Journal of Physiology 2007 293 3 R974 R980 2-s2.0-34548452026 10.1152/ajpregu.00147.2007 (Pubitemid 47358914)
11. Gillespie E. L., White C. M., Kardas M., Lindberg M., Coleman C. I., The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care 2005 28 9 2261 2266 2-s2.0-24144490705 10.2337/diacare.28.9.2261 (Pubitemid 41242483)
12. Tikellis C., Wookey P. J., Candido R., Andrikopoulos S., Thomas M. C., Cooper M. E., Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 2004 53 4 989 997 2-s2.0-1842475446 10.2337/diabetes.53.4.989 (Pubitemid 38436611)
13. Kanauchi M., Nakajima M., Saito Y., Kanauchi K., Pancreatic beta-cell function and insulin sensitivity in Japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus. Metabolism 2003 52 4 476 481 2-s2.0-0037737695 10.1053/meta.2003.50078 (Pubitemid 36773271)
14. Forouhi N. G., Sattar N., McKeigue P. M., Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. International Journal of Obesity 2001 25 9 1327 1331 2-s2.0-0034840453 10.1038/sj.ijo.0801723 (Pubitemid 32835450)
15. Toblli J. E., Mũoz M. C., Cao G., Mella J., Pereyra L., Mastai R., ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese zucker rats. Obesity 2008 16 4 770 776 2-s2.0-41549156590 10.1038/oby.2007.114 (Pubitemid 351465631)
16. Yamagishi S. I., Matsui T., Nakamura K., Inoue H., Takeuchi M., Ueda S., Okuda S., Imaizumi T., Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species. Ophthalmic Research 2007 40 1 10 15 2-s2.0-37349025554 10.1159/000111152